You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Moodys
Colorcon
Mallinckrodt
Medtronic

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Litigation Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2010)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2010)

Docket   Start Trial Date Filed 2010-04-05
Court District Court, D. New Jersey Date Terminated 2014-10-16
Cause 35:271 Patent Infringement Assigned To Joel A. Pisano
Jury Demand None Referred To
Parties CADILA HEALTHCARE LIMITED; ETHYPHARM, S.A.; TAKEDA PHARMACEUTICAL COMPANY LIMITED; TAKEDA PHARMACEUTICALS AMERICA, INC.; TAKEDA PHARMACEUTICALS LLC; TAKEDA PHARMACEUTICALS NORTH AMERICA, INC.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 5,464,632; 6,328,994; 7,399,485; 7,431,942; 7,875,292
Attorneys CARISSA L. RODRIGUE; DILLON KIM; ELINA SLAVIN; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; JOSEPH A. BOYLE; MARK H. ANANIA; PETER HWICHAN NOH; SYMONE J. REDWINE; VINCENT P. RAO; WILLIAM J. HELLER
Firms Hogan Lovells US LLP; Kelley Drye Warren, LLP; McCarter & English, LLP; McCarter and English, LLP; Polsinelli PC
Link to Docket External link to docket
Small Molecule Drugs cited in TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-04-05 1 Complaint lansoprazole of U.S. Patent No. 5,464,632 ("the '632 Patent"). …licensee of U.S. Patent No. 6,328,994 ("the '994 Patent") and U.S. Patent No. 7,431,942 (…#39;632 Patent. Ethypharm seeks relief in this action solely with respect to the '632 Patent. …#39;994 Patent, and Plaintiff Takeda LLC is the exclusive licensee. A copy of the '994 Patent is attached…#39;994 Patent, and Plaintiff Takeda LLC is the exclusive licensee. A copy of the '942 Patent is attached External link to document
2011-10-05 113 Opinion the “ ‘994 patent”), 7,431,942 the “ ‘942 patent”), and 5,464,632 (the “ ‘632 patent”). … three patents alleged to cover Takeda’s Prevacid SoluTab product (“SoluTab”): U.S. Patent Nos. 6,… I. The Technology and Patents-In-Suit The three patents at issue claim a pharmaceutical…to prevail in a patent infringement suit, a plaintiff must establish that the patent claim “covers …A[i]t is a bedrock principle of patent law that the claims of a patent define the invention to which External link to document
2011-10-19 116 Brief 1, 3 U.S. Patent No. 5,464,632 …disintegrating agent" in U.S. Patent No. 5,464,632, (Docket -No. 69-2, Ex. 3 to the Moriarty…phrases found in U.S. Patent No. 6,328,994 (the "994 patent") and U.S. Patent No. 7,431,942 (the…;994 patent, Col. 2, ln. 16 - 17; '942 patent, Col. 2 , ln. 19 - 20. 7 '994 patent, Col.… in the 5 '994 patent Col. 37, ln. 21 - 26; '942 patent Col. 37, in. 32- 36. External link to document
2011-11-07 117 terms in U.S. Patent No. 6,328,994 (the "'994 patent") and U.S. Patent No. 7,431,942 …claim construction ruling to the related patent U.S. Patent No. 7,875,292. …±10%). (Opinion at 8, 10; '994 patent, claim 2; '942 patent, claim 1.)2 In adopting Plaintiffs…7,431,942 (the "'942 patent")1. Among other disputed terms, the Court construed "fine granules…µm or less" from Claim 1 of the '994 patent to mean "fine granules up to and including External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Moodys
Colorcon
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.